Hatteras Venture Partners, founded in 2000, is a venture fund based in Durham, North Carolina. Specializing in financing biomedical companies, the fund focuses on BioTech, Healthcare, Life Science, and Medical Device sectors. Clay Thorp is a key partner at Hatteras Venture Partners, which has invested in 100 companies and successfully exited 22. Some of their portfolio companies include Code Biotherapeutics and HistoSonics. The fund caters to various stages from Pre-Seed to Series D, offering a broad spectrum of investment opportunities in the healthcare industry. For more information, visit their website at www.hatterasvp.com.